These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 7540822)

  • 21. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities.
    Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B
    Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative contributions from neuronal and endothelial nitric oxide synthases to regional cerebral blood flow changes during forebrain ischemia in rats.
    Santizo R; Baughman VL; Pelligrino DA
    Neuroreport; 2000 May; 11(7):1549-53. PubMed ID: 10841375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysmorphogenic effects of nitric oxide (NO) and NO-synthase inhibition: studies with intra-amniotic injections of sodium nitroprusside and NG-monomethyl-L-arginine.
    Lee QP; Juchau MR
    Teratology; 1994 Jun; 49(6):452-64. PubMed ID: 7538231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced renal allograft rejection by inhibitors of nitric oxide synthase: a nonimmunologic influence on alloreactivity.
    Stojanovic T; Gröne HJ; Gieseler RK; Klanke B; Schlemminger R; Tsikas D; Gröne EF
    Lab Invest; 1996 Feb; 74(2):496-512. PubMed ID: 8780167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of L-NMMA and L-NNA on the selective ATP-induced enhancement of intratumoral blood flow.
    Natori Y; Moriguchi M; Fujiwara S; Takeshita I; Fukui M; Iwaki T; Kanaide H
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):120-7. PubMed ID: 1727133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capillary reperfusion after L-arginine, L-NMMA, and L-NNA treatment in cheek pouch microvasculature.
    Bertuglia S; Colantuoni A; Intaglietta M
    Microvasc Res; 1995 Sep; 50(2):162-74. PubMed ID: 8538497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible inactivation of endothelial nitric oxide synthase by NG-nitro-L-arginine.
    Mayer B; Schmid M; Klatt P; Schmidt K
    FEBS Lett; 1993 Oct; 333(1-2):203-6. PubMed ID: 7693510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of inhibition of porcine brain nitric oxide synthase by the antinociceptive drug 7-nitro-indazole.
    Mayer B; Klatt P; Werner ER; Schmidt K
    Neuropharmacology; 1994 Nov; 33(11):1253-9. PubMed ID: 7532811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
    Cooper GR; Mialkowski K; Wolff DJ
    Arch Biochem Biophys; 2000 Mar; 375(1):183-94. PubMed ID: 10683266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of N(G)-monomethyl-L-arginine on Ca(2+) current and nitric-oxide synthase in rat ventricular myocytes.
    Matsumoto S; Takahashi T; Ikeda M; Nishikawa T; Yoshida S; Kawase T
    J Pharmacol Exp Ther; 2000 Jul; 294(1):216-23. PubMed ID: 10871315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline.
    Furfine ES; Harmon MF; Paith JE; Knowles RG; Salter M; Kiff RJ; Duffy C; Hazelwood R; Oplinger JA; Garvey EP
    J Biol Chem; 1994 Oct; 269(43):26677-83. PubMed ID: 7523410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.
    Finkel MS; Oddis CV; Mayer OH; Hattler BG; Simmons RL
    J Pharmacol Exp Ther; 1995 Feb; 272(2):945-52. PubMed ID: 7531767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible nitric oxide synthase is involved in acid-induced gastric hyperemia in rats and mice.
    Phillipson M; Henriksnäs J; Holstad M; Sandler S; Holm L
    Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G154-62. PubMed ID: 12646421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
    Cooper GR; Barr A; Wolff DJ
    Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasomotor responses of canine coronary arterial rings to NG-monomethyl-L-arginine and N omega nitro L-arginine methyl ester.
    Winn MJ; Asante NK; Ku DD
    J Pharmacol Exp Ther; 1993 Jan; 264(1):265-70. PubMed ID: 8423529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase.
    Robertson CA; Green BG; Niedzwiecki L; Harrison RK; Grant SK
    Biochem Biophys Res Commun; 1993 Dec; 197(2):523-8. PubMed ID: 7505570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
    McCall TB; Feelisch M; Palmer RM; Moncada S
    Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation.
    Klatt P; Schmidt K; Brunner F; Mayer B
    J Biol Chem; 1994 Jan; 269(3):1674-80. PubMed ID: 7507482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allosteric regulation of neuronal nitric oxide synthase by tetrahydrobiopterin and suppression of auto-damaging superoxide.
    Kotsonis P; Fröhlich LG; Shutenko ZV; Horejsi R; Pfleiderer W; Schmidt HH
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):767-76. PubMed ID: 10698705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode.
    Lefèvre-Groboillot D; Frapart Y; Desbois A; Zimmermann JL; Boucher JL; Gorren AC; Mayer B; Stuehr DJ; Mansuy D
    Biochemistry; 2003 Apr; 42(13):3858-67. PubMed ID: 12667076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.